{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T17:15:06Z","timestamp":1758820506795,"version":"3.44.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Studies on the impact of blood glucose indicators on metabolism remain relatively scarce. The aim of this study was to investigate the associations between blood glucose indicators and metabolic disorders in China.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Data were from the Thyroid disorders, Iodine status and Diabetes Epidemiological survey (TIDE survey), which randomly selected 31 cities from 31 provinces in the Chinese mainland. A total of 68,383 participants without preexisting diabetes and have complete data on blood glucose, lipids, and blood pressure were included in the analysis. The diabetic population was divided into seven groups based on different types of elevated blood glucose levels, including fasting plasma glucose (FPG), postprandial glucose (PPG), and hemoglobin A1c (HbA1c): FPG \u22657 mmol\/L; PPG \u226511.1 mmol\/L; HbA1c \u22656.5%; FPG \u22657 mmol\/L and PPG \u226511.1 mmol\/L; FPG \u22657 mmol\/L and HbA1c \u22656.5%; PPG \u226511.1 mmol\/L and HbA1c \u22656.5%; FPG \u22657 mmol\/L, PPG \u226511.1 mmol\/L, and HbA1c \u22656.5%. The effects of each blood glucose indicator on metabolism were investigated separately. Weighted calculation was applied during the analysis, with the weighting coefficient based on the number of people corresponding to the population characteristics of each sample in the 2010 Chinese Census. A logistic regression model with restricted cubic splines (RCS) was employed to characterize the nonlinear associations of age and body mass index (BMI) with the risk of diabetes subtypes defined by distinct blood glucose indicators elevations, as well as the relationships between different blood glucose indicators (FPG, PPG, HbA1c) and the risk of metabolic disorders such as hypertension, hypertriglyceridemia, hypercholesterolemia, high low-density lipoprotein cholesterol (high LDL-C) and low high-density lipoprotein cholesterol (low HDL-C).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among individuals with diabetes, elevated PPG alone was the most common abnormality, affecting 26.96% (1382\/5127) of the population. Among the seven groups with only one elevated blood glucose indicator, individuals with elevated PPG alone exhibited the highest mean levels of triglycerides (TG) at 2.11 mmol\/L (95% confidence interval [CI]: 1.97\u20132.25 mmol\/L, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.004), total cholesterol (TC) at 5.26 mmol\/L (95% CI: 5.18\u20135.33 mmol\/L, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt;0.001), and low-density lipoprotein cholesterol (LDL-C) at 3.12 mmol\/L, (95% CI: 3.06\u20133.19 mmol\/L, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.001). Individuals with elevated PPG alone showed a high prevalence of hypertension (806\/1382, 58.32%), hypertriglyceridemia (676\/1382, 48.91%), hypercholesterolemia (694\/1382, 50.22%), High LDL-C (525\/1382, 37.94%), and Low HDL-C (364\/1382, 26.34%). The association of age and BMI with the risk of diabetes revealed that the older the patient, the steeper the RCS curve for the odds ratio (OR) of diabetes with elevated PPG alone (age = 60, OR = 2.79, 95% CI [2.49\u20133.12], <jats:italic toggle=\"yes\">P<\/jats:italic> &lt;0.01). Similarly, as BMI increased, the RCS curve for the OR of diabetes with elevated HbA1c alone also steepened (BMI = 35, OR = 3.75, 95% CI [3.23\u20134.35], <jats:italic toggle=\"yes\">P<\/jats:italic> &lt;0.001). Additionally, the RCS yielded a positive association between blood glucose indicators and metabolic diseases risk. In individuals with diabetes, RCS for both the ORs of metabolic diseases (hypertension, hypertriglyceridemia, hypercholesterolemia, high LDL-C, low HDL-C) and the levels of metabolic indicators (TG, TC, LDL-C, HDL-C) revealed some inflection points within the ranges of FPG 5\u20136 mmol\/L, PPG 6\u20138 mmol\/L, and HbA1c 5.5\u20136.0%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>PPG is more closely related to metabolic disorders than FPG and HbA1c in people with diabetes. For patients with diabetes and metabolic disorders, it may be necessary to monitor blood glucose fluctuations within specific ranges (FPG 5\u20136 mmol\/L, PPG 6\u20138 mmol\/L, and HbA1c 5.5\u20136.0%).<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003701","type":"journal-article","created":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T02:48:49Z","timestamp":1754448529000},"page":"2159-2169","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Association between blood glucose indicators and metabolic diseases in the Chinese population: A national cross-sectional study"],"prefix":"10.1097","volume":"138","author":[{"given":"Lijun","family":"Tian","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Di","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Teng","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"R1-20250905","article-title":"Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050","author":"Zhang","year":"2025","journal-title":"Chin Med J"},{"issue":"Suppl 1","key":"R2-20250905","first-page":"S15","article-title":"2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"R3-20250905","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"R4-20250905","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/CM9.0000000000003428","article-title":"Epidemiological status, development trends, and risk factors of disability-adjusted life years due to diabetic kidney disease: A systematic analysis of Global Burden of Disease Study 2021","volume":"138","author":"Li","year":"2025","journal-title":"Chin Med J"},{"key":"R5-20250905","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/ATVBAHA.117.310221","article-title":"Highlighting diabetes mellitus: The epidemic continues","volume":"38","author":"Schmidt","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 1","key":"R6-20250905","first-page":"S40","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: Standards of medical care in diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"R7-20250905","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/M15-3016","article-title":"Diagnosis and management of diabetes: Synopsis of the 2016 American Diabetes Association standards of medical care in diabetes","volume":"164","author":"Chamberlain","year":"2016","journal-title":"Ann Intern Med"},{"key":"R8-20250905","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-021-05585-2","article-title":"Interpreting global trends in type 2 diabetes complications and mortality","volume":"65","author":"Ali","year":"2022","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"R9-20250905","first-page":"S64","article-title":"Diagnosis and classification of diabetes mellitus","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"R10-20250905","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41591-024-02908-9","article-title":"Continuous glucose monitoring and intrapersonal variability in fasting glucose","volume":"30","author":"Shilo","year":"2024","journal-title":"Nat Med"},{"key":"R11-20250905","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1001\/jama.2016.11326","article-title":"Evaluating elevated hemoglobin","volume":"316","author":"Reeves","year":"2016","journal-title":"JAMA"},{"key":"R12-20250905","doi-asserted-by":"crossref","first-page":"e7293","DOI":"10.1136\/bmj.e7293","article-title":"Use of HbA1c in the diagnosis of diabetes","volume":"345","author":"Farmer","year":"2012","journal-title":"BMJ"},{"key":"R13-20250905","doi-asserted-by":"crossref","first-page":"e1000278","DOI":"10.1371\/journal.pmed.1000278","article-title":"Markers of dysglycaemia and risk of coronary heart disease in people without diabetes: Reykjavik prospective study and systematic review","volume":"7","author":"Sarwar","year":"2010","journal-title":"PLoS Med"},{"key":"R14-20250905","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCULATIONAHA.118.036068","article-title":"Glycemic control, cardiac autoimmunity, and long-term risk of cardiovascular disease in type 1 diabetes mellitus","volume":"139","author":"Sousa","year":"2019","journal-title":"Circulation"},{"key":"R15-20250905","doi-asserted-by":"crossref","first-page":"6615295","DOI":"10.1155\/2020\/6615295","article-title":"Effects of fasting-mimicking diet and specific meal replacement foods on blood glucose control in patients with type 2 diabetes: A randomized controlled trial","volume":"2020","author":"Tang","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"R16-20250905","doi-asserted-by":"crossref","first-page":"e0258771","DOI":"10.1371\/journal.pone.0258771","article-title":"Postprandial plasma glucose excursion is associated with an atherogenic lipid profile in individuals with type 2 diabetes mellitus: A cross-sectional study","volume":"16","author":"Cheng","year":"2021","journal-title":"PLoS One"},{"key":"R17-20250905","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2337\/dc13-1102","article-title":"Association between glycemic control and morning blood pressure surge with vascular endothelial dysfunction in type 2 diabetic patients","volume":"37","author":"Yoda","year":"2014","journal-title":"Diabetes Care"},{"key":"R18-20250905","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12933-020-00997-7","article-title":"Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat","volume":"19","author":"Park","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"R19-20250905","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/dc18-0918","article-title":"Effects of high blood pressure on cardiovascular disease events among Chinese adults with different glucose metabolism","volume":"41","author":"Tian","year":"2018","journal-title":"Diabetes Care"},{"key":"R20-20250905","article-title":"Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study","volume":"369","author":"Li","year":"2020","journal-title":"BMJ"},{"issue":"Suppl 1","key":"R21-20250905","first-page":"S13","article-title":"2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"R22-20250905","first-page":"221","article-title":"Chinese guidelines for lipid management (2023) (in Chinese)","volume":"51","year":"2023","journal-title":"Chin J Cardiol"},{"key":"R24-20250905","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1097\/CM9.0000000000001407","article-title":"Population diversity of cardiovascular outcome trials and real-world patients with diabetes in a Chinese tertiary hospital","volume":"134","author":"Zhou","year":"2021","journal-title":"Chin Med J"},{"issue":"Suppl 1","key":"R25-20250905","first-page":"S17","article-title":"2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"R26-20250905","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus","volume":"37","author":"Kautzky-Willer","year":"2016","journal-title":"Endocr Rev"},{"key":"R27-20250905","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12020-014-0195-0","article-title":"Impact of social determinants of health on outcomes for type 2 diabetes: A systematic review","volume":"47","author":"Walker","year":"2014","journal-title":"Endocrine"},{"key":"R28-20250905","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12955-018-1021-9","article-title":"Related factors of quality of life of type 2 diabetes patients: A systematic review and meta-analysis","volume":"16","author":"Jing","year":"2018","journal-title":"Health Qual Life Outcomes"},{"key":"R29-20250905","doi-asserted-by":"crossref","first-page":"R75","DOI":"10.1530\/JOE-14-0024","article-title":"Metabolic profiling in diabetes","volume":"221","author":"Suhre","year":"2014","journal-title":"J Endocrinol"},{"key":"R30-20250905","doi-asserted-by":"crossref","first-page":"888599","DOI":"10.3389\/fendo.2022.888599","article-title":"Comparisons of the relationships between multiple lipid indices and diabetic kidney disease in patients with type 2 diabetes: A cross-sectional study","volume":"13","author":"Lu","year":"2022","journal-title":"Front Endocrinol"},{"key":"R31-20250905","doi-asserted-by":"crossref","first-page":"6184","DOI":"10.3390\/ijms23116184","article-title":"Genetic evidence for a causal relationship between hyperlipidemia and type 2 diabetes in mice","volume":"23","author":"Shi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R32-20250905","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.3390\/cells11172669","article-title":"Phenotypic and genetic evidence for a more prominent role of blood glucose than cholesterol in atherosclerosis of hyperlipidemic mice","volume":"11","author":"Abramson","year":"2022","journal-title":"Cells"},{"key":"R33-20250905","doi-asserted-by":"crossref","first-page":"133184","DOI":"10.1016\/j.ijcard.2025.133184","article-title":"Association of fasting blood glucose with in-hospital mortality in acute coronary syndrome patients with different glycemic statuses: Findings from the CCC-ACS project","volume":"430","author":"Fan","year":"2025","journal-title":"Int J Cardiol"},{"key":"R34-20250905","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/CM9.0000000000002894","article-title":"Bidirectional relationship between type 2 diabetes mellitus and coronary artery disease: Prospective cohort study and genetic analyses","volume":"137","author":"Zhang","year":"2024","journal-title":"Chin Med J"},{"key":"R35-20250905","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2337\/dc17-0245","article-title":"The prognostic value of fasting plasma glucose, two-hour postload glucose, and HbA1c in patients with coronary artery disease: A report from EUROASPIRE IV: A survey from the European Society of Cardiology","volume":"40","author":"Shahim","year":"2017","journal-title":"Diabetes Care"},{"key":"R36-20250905","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/jc.2005-1005","article-title":"Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: Lessons from the San Luigi Gonzaga Diabetes Study","volume":"91","author":"Cavalot","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"R37-20250905","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"R38-20250905","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/dc10-0389","article-title":"Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients","volume":"33","author":"Rizzo","year":"2010","journal-title":"Diabetes Care"},{"key":"R39-20250905","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00125-018-4778-9","article-title":"Type 2 diabetes mellitus, brain atrophy and cognitive decline in older people: A longitudinal study","volume":"62","author":"Callisaya","year":"2019","journal-title":"Diabetologia"},{"key":"R40-20250905","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/01.wnl.0000224760.22802.e8","article-title":"Postprandial plasma glucose excursions and cognitive functioning in aged type 2 diabetics","volume":"67","author":"Abbatecola","year":"2006","journal-title":"Neurology"},{"key":"R41-20250905","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41574-018-0122-1","article-title":"Circadian clocks and insulin resistance","volume":"15","author":"Stenvers","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"R42-20250905","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.2337\/dc24-0879","article-title":"Discrepancy between genetically predicted and observed BMI predicts incident type 2 diabetes","volume":"47","author":"Rhee","year":"2024","journal-title":"Diabetes Care"},{"key":"R43-20250905","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/pedi.13297","article-title":"HbA1c percentiles and the association between BMI, age, gender, puberty, and HbA1c levels in healthy German children and adolescents","volume":"23","author":"Hovestadt","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"R44-20250905","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.2337\/dc21-1062","article-title":"Prediabetes defined by first measured HbA1c predicts higher cardiovascular risk compared with HbA1c in the diabetes range: A cohort study of nationwide registries","volume":"44","author":"Yahyavi","year":"2021","journal-title":"Diabetes Care"},{"key":"R45-20250905","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12944-020-01326-3","article-title":"Association between fasting plasma glucose and nonalcoholic fatty liver disease in a nonobese Chinese population with normal blood lipid levels: A prospective cohort study","volume":"19","author":"Zou","year":"2020","journal-title":"Lipids Health Dis"},{"key":"R46-20250905","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4065\/78.4.447","article-title":"Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus","volume":"78","author":"Gerich","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"R47-20250905","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/s41580-018-0044-8","article-title":"Metabolites as regulators of insulin sensitivity and metabolism","volume":"19","author":"Yang","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R48-20250905","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1152\/physrev.00015.2017","article-title":"Interorgan metabolic crosstalk in human insulin resistance","volume":"98","author":"Gancheva","year":"2018","journal-title":"Physiol Rev"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003701","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T04:00:33Z","timestamp":1757044833000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":47,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003701","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"type":"print","value":"0366-6999"},{"type":"electronic","value":"2542-5641"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"2025-04-18","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}